PARP1 and small cell lung carcinoma: SCLC-A cell lines show a wide spectrum of sensitivity to platinum: high expression of SLFN11 in SCLC-A cell lines is correlated with higher sensitivity to both cisplatin and PARPis, whereas low expression of SLFN11 within this subgroup is accompanied by lower responsiveness to both platinum and PARP inhibition [19].